Minneapolis [May 06, 2026] – Francis Medical, Inc., a privately held medical device company based in Maple Grove, Minn., today announced that Naveen Kella, MD, of The Urology Place has successfully completed the first commercial procedures in San Antonio, Texas, using the Vanquish® Water Vapor Ablation System, a minimally invasive technology designed to ablate targeted prostate tissue. Dr. Kella, who was also a clinical investigator in the VAPOR 2 pivotal study, performed the procedures on patients diagnosed with localized prostate cancer at Huebner Ambulatory Surgery Center.

Minneapolis, MN [April 16, 2026] – Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S. commercial launch with the first commercial procedures performed using the Vanquish® Water Vapor Ablation System in the Southeast, a minimally invasive technology designed to ablate targeted prostate tissue.

MINNEAPOLIS (March 5, 2026) – Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) procedures in Arizona using the Vanquish® Water Vapor Ablation System for prostate tissue ablation.

MINNEAPOLIS (Dec. 2, 2025) – Francis Medical, Inc.,a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System